Showing results (171-180 of 186) with videos related to
Sort By:
Pageof 19
Arthritis and Rheumatism|December 4, 2012
Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritisM Bonelli, E Ferner, L Göschl, et al.The American Journal of Pathology|October 1, 1992
Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysisR V Lloyd, L Jin, A Chang, et al.Gene Therapy|September 16, 2005
Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefitK C Lee, D A Hamstra, S Bullarayasamudram, et al.Magma (New York, N.Y.)|December 8, 2004
Diffusion imaging for evaluation of tumor therapies in preclinical animal modelsB A Moffat, D E Hall, J Stojanovska, et al.Journal of Computer Assisted Tomography|January 1, 1987
Clinical magnetic susceptibility mapping of the brainI R Young, S Khenia, D G Thomas, et al.Gene Therapy|June 29, 2000
Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategyL D Stegman, A Rehemtulla, D A Hamstra, et al.Journal of Computer Assisted Tomography|January 1, 1987
Clinical use of rapid T2 weighted partial saturation sequences in MR imagingG M Bydder, J A Payne, A G Collins, et al.Urology|December 22, 1999
Early castration reduces prostatic carcinogenesis in transgenic miceM H Eng, L G Charles, B D Ross, et al.Radiology|December 1, 1992
Proceedings of a National Cancer Institute workshop: MR spectroscopy and tumor cell biologyW G Negendank, T R Brown, J L Evelhoch, et al.The Journal of Urology|September 29, 1998
Longitudinal cohort analysis of lethal prostate cancer progression in transgenic miceC X Hsu, B D Ross, C E Chrisp, et al.Pageof 19